Healthy Extracts Raises $459,500 Net via 13% Secured Convertible Note With 12.5% Revenue Royalty
HYEX sits 68% above its 52-week low of $0.805.
Summary
Healthy Extracts raised $459,500 net through a $555,556 secured convertible note paying 13% interest and 12.5% of gross revenue from March 2027, secured by substantially all company assets. For a company with $143,267 on hand, the cash buys runway at a high cost and with restrictive covenants.
Key Events · Financing and Capital Events · HYEX
-
Secured Convertible Note Closed
On November 10, 2026 the company issued a $555,556 secured promissory note to Hinterland Partners LLC with a $55,556 original issue discount, 13% annual interest and a 30-month maturity.
-
Net Proceeds of $459,500
The company received $459,500 after the holder withheld $5,500 for legal fees, $5,000 for due diligence and $30,000 for placement agent Carter, Terry & Company.
-
12.5% Revenue Royalty From March 2027
Beginning March 1, 2027 the company must pay 12.5% of the prior month's gross revenue monthly until the note is extinguished, applied first to accrued interest and then principal.
-
All Assets Pledged as Collateral
A security agreement grants the holder a security interest in substantially all assets of the company and its subsidiaries, terminating automatically on a NASDAQ, NYSE or NYSE American listing.
Analysis · HYEX · Life Sciences
Healthy Extracts is funding itself with a small, expensive secured note rather than equity, a choice that matters given the $143,267 of cash against $9.17 million of current liabilities reported in its November 16 10-Q. On a $555,556 face amount, the company nets $459,500 after a $55,556 original issue discount and roughly $40,500 of fees, pays 13% interest, and pledges substantially all assets of the company and its subsidiaries. The royalty is the costly part: from March 1, 2027 it must hand over 12.5% of gross revenue every month until the note is gone, which on a business with roughly $619,000 of quarterly revenue is a meaningful claim on cash. Conversion at a fixed $2.00 is far above today's $1.35 price, so near-term dilution from conversion is unlikely unless the stock recovers; the real risk is the default trigger, where the conversion price falls to 75% of the lowest recent traded price and the balance jumps to 150%. The note also blocks variable-rate financings for 18 months and gives the holder participation and most-favored-nation rights, narrowing future financing options.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HYEX was trading at $1.35 on OTC in the Life Sciences sector, with a market capitalization of approximately $19.9M. The 52-week trading range was $0.81 to $4.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.